430 related articles for article (PubMed ID: 6519129)
1. Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease.
Keller F; Maiga M; Neumayer HH; Lode H; Distler A
Eur J Drug Metab Pharmacokinet; 1984; 9(3):275-82. PubMed ID: 6519129
[TBL] [Abstract][Full Text] [Related]
2. Drug protein binding and the nephrotic syndrome.
Gugler R; Azarnoff DL
Clin Pharmacokinet; 1976; 1(1):25-35. PubMed ID: 797490
[TBL] [Abstract][Full Text] [Related]
3. Disease-induced changes in the plasma binding of basic drugs.
Piafsky KM
Clin Pharmacokinet; 1980; 5(3):246-62. PubMed ID: 6156048
[TBL] [Abstract][Full Text] [Related]
4. Drug dosage in renal disease.
Dettli L
Clin Pharmacokinet; 1976; 1(2):126-34. PubMed ID: 797495
[TBL] [Abstract][Full Text] [Related]
5. Rationale for monitoring free drug levels.
Levy RH; Moreland TA
Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():1-9. PubMed ID: 6705421
[TBL] [Abstract][Full Text] [Related]
6. Pitfalls of pharmacokinetic dosage guidelines in renal insufficiency.
Turnheim K
Eur J Clin Pharmacol; 1991; 40(1):87-93. PubMed ID: 2060552
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
Johnsson G; Regàrdh CG
Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiological and disease-induced changes in drug distribution volume: pharmacokinetic implications.
Klotz U
Clin Pharmacokinet; 1976; 1(3):204-18. PubMed ID: 797498
[TBL] [Abstract][Full Text] [Related]
9. Importance of protein binding for the interpretation of serum or plasma drug concentrations.
Greenblatt DJ; Sellers EM; Koch-Weser J
J Clin Pharmacol; 1982; 22(5-6):259-63. PubMed ID: 7107972
[TBL] [Abstract][Full Text] [Related]
10. Simple model to explain effects of plasma protein binding and tissue binding on calculated volumes of distribution, apparent elimination rate constants and clearances.
Wagner JG
Eur J Clin Pharmacol; 1976; 10(6):425-32. PubMed ID: 1001358
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics in renal disease.
Levy G
Am J Med; 1977 Apr; 62(4):461-5. PubMed ID: 851113
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of free drug monitoring.
Dasgupta A
Clin Chem Lab Med; 2002 Oct; 40(10):986-93. PubMed ID: 12476936
[TBL] [Abstract][Full Text] [Related]
13. Drug distribution and binding.
Oie S
J Clin Pharmacol; 1986; 26(8):583-6. PubMed ID: 3793947
[TBL] [Abstract][Full Text] [Related]
14. [Plasma binding of drugs in chronic renal failure].
Riant P; Barre J; Albengres E; Lemaire M; Tillement JP
Nephrologie; 1986; 7(3):89-93. PubMed ID: 3774085
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic parameters: which are necessary to define a drug substance?
Benet LZ
Eur J Respir Dis Suppl; 1984; 134():45-61. PubMed ID: 6586486
[TBL] [Abstract][Full Text] [Related]
16. A physiologically based pharmacokinetic model to predict the pharmacokinetics of highly protein-bound drugs and the impact of errors in plasma protein binding.
Ye M; Nagar S; Korzekwa K
Biopharm Drug Dispos; 2016 Apr; 37(3):123-41. PubMed ID: 26531057
[TBL] [Abstract][Full Text] [Related]
17. Use of unbound volumes of drug distribution in pharmacokinetic calculations.
Stepensky D
Eur J Pharm Sci; 2011 Jan; 42(1-2):91-8. PubMed ID: 21050885
[TBL] [Abstract][Full Text] [Related]
18. Plasma protein binding and distribution characteristics of drugs as indices of their hemodialyzability.
Gwilt PR; Perrier D
Clin Pharmacol Ther; 1978 Aug; 24(2):154-61. PubMed ID: 679594
[TBL] [Abstract][Full Text] [Related]
19. Effect of concentration-dependent binding to plasma proteins on the pharmacokinetics and pharmacodynamics of disopyramide.
Giacomini KM; Blaschke TF
Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():42-8. PubMed ID: 6705426
[TBL] [Abstract][Full Text] [Related]
20. Errors in interpretation of data from equilibrium dialysis protein binding experiments.
Behm HL; Wagner JG
Res Commun Chem Pathol Pharmacol; 1979 Oct; 26(1):145-60. PubMed ID: 515500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
